Oss, NL May 20, 2025
BioConnection is pleased to announce the appointment of Mireille Sanders as member of our Supervisory Board. She succeeds Sijmen de Vries at this position who steps back at the same time. We are happy that Ms. Sanders continues this position on our board with her wide experience and knowledge. Upon her appointment, Ms. Sanders commented, “It’s a privilege to join the Supervisory Board, and I look forward to collaborating with the BioConnection team. Throughout my career, I’ve been committed to driving strong partnerships between CMO’s and the customers to bring innovative medicines to patients worldwide. I’m enthusiastic about supporting the company’s continued growth and success.”
BioConnection is grateful for all the work, advice and support that Mr. de Vries has given to our company in the last 18 years. It has been a fruitful and successful cooperation.
Alexander Willemse, PhD, MSc
Chief Executive Officer
About BioConnection
BioConnection (BCO) is a specialized contract development and manufacturing organization (specialized CMO) serving the pharmaceutical industry. We specialize in the production of injectable (bio)pharmaceutical products, catering to a global clientele from our FDA and EMA-certified facility in Oss, North Brabant. Our comprehensive range of services includes Chemistry, Manufacturing, and Controls (CMC), encompassing drug product manufacturing process development, Fill & Finish for liquid, and freeze-drying (lyophilization) presentations at both clinical and commercial scales in vials and syringes. Additionally, we offer specialized small-scale (hand fill) production for personalized medicines, ensuring adaptability and precision in pharmaceutical manufacturing.